Silke Schwiebert

Statistics

Publications

Citations

367

H-Index

Active since

2011

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Freie Universität Berlin

Deutsches Konsortium für Translationale Krebsforschung

Humboldt-Universität zu Berlin

German Cancer Research Center

Silke Schwiebert is an author at Charité - Universitätsmedizin Berlin specializing in life sciences, immunotherapy, and chimeric antigen receptor t-cell therapy.

Publications per year

2011–2021

Publications

CD171- and GD2-specific CAR-T cells potently target retinoblastoma cells in preclinical in vitro testing

Lena Andersch, Josefine Radke, Anika Klaus et al. · BMC Cancer · 2019 · 70 citations · Full text

Medicine, Cancer Biology, Oncology +16

A Reproducible Bioprinted 3D Tumor Model Serves as a Preselection Tool for CAR T Cell Therapy Optimization

Laura Grunewald, Tobias Lam, Lena Andersch et al. · Frontiers in Immunology · 2021 · 57 citations · Full text

Life Sciences, Immunology, Oncology +17

Proplatelet formation is selectively inhibited by collagen type I through Syk-independent GPVI signaling

Daniela Semeniak, Rebecca Kulawig, David Stegner et al. · Journal of Cell Science · 2016 · 54 citations

Life Sciences, Cell Biology, Molecular Biology +17

CD28 Co-Stimulus Achieves Superior CAR T Cell Effector Function against Solid Tumors Than 4-1BB Co-Stimulus

Ana Textor, Laura Grunewald, Kathleen Anders et al. · Cancers · 2021 · 42 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor-Derived Extracellular Vesicles Impair CD171-Specific CD4+ CAR T Cell Efficacy

Solin Ali, Karin Toews, Silke Schwiebert et al. · Frontiers in Immunology · 2020 · 37 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 10